在儿童和青少年中喘和过敏性鼻炎的围产期危险因素
Se Hwan Hwang1, Hyesoo Shin1, Gulnaz Stybayeva2
1Department of Otolaryngology-Head and Neck Surgery, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.
Clinical and experimental otorhinolaryngology
|April 7, 2024
概括
男性性别,剖腹产和家族过敏史增加了喘和过敏性鼻炎的风险. 独家母乳养,更长的母乳养时间和兄弟姐妹提供了对这些呼吸道过敏疾病的保护.
科学领域:
- 儿科过敏和免疫学
- 环境健康 环境健康
- 流行病学 流行病学
背景情况:
- 过敏性鼻炎和喘是儿童的重大健康问题.
- 了解早期暴露对呼吸道过敏的影响对于预防至关重要.
研究的目的:
- 评估与出生和产后因素以及儿童和青少年过敏性鼻炎和喘风险之间的关联.
主要方法:
- 对31项研究 (218,899名参与者) 进行了元分析.
- 对各种曝光计算了聚合赔率比率和95%置信区间.
- 使用纽卡斯尔-太华量表来评估方法质量.
主要成果:
- 男性性别,剖腹产和父母过敏史与风险增加有关.
- 低出生体重,产妇年龄和早产没有显著的关联.
- 纯母乳养,更长的母乳养时间 (>6个月),出生顺序较晚,以及兄弟姐妹具有保护作用.
结论:
- 男性性别,剖腹产和家族过敏史是儿童过敏性鼻炎和喘的危险因素.
- 哺乳和有兄弟姐妹是预防这些疾病的保护因素.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management
391
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
391
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
277
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
277
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
284
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
284


